Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Clinical trial NCT06989957 · RECRUITING
Trial details
- NCT number
- NCT06989957
- Sponsor
- Johns Hopkins University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-17
- Primary completion
- 2028-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.